Cipla Q4 results preview: Revenue, PAT growth, EBITDA, key highlights here
Pharma major, Cipla will be in focus on Friday ahead of its Q4 numbers. The company is expected to report double-digit growth in the bottom-line and top-line front for the quarter. Also, EBITDA margins are expected to improve ahead. Cipla has a strong product launch pipeline which is expected to play out well for the company ahead.